Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  AstraZeneca PLC    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Analyst Recommendations on ASTRAZENECA PLC
01/15ASTRAZENECA : Deutsche Bank Initiates Coverage on AstraZeneca With Buy Rating
MT
01/15ASTRAZENECA : Buy rating from Deutsche Bank
MD
01/15ASTRAZENECA : Buy rating from Berenberg
MD
01/14ASTRAZENECA : UBS reaffirms its Neutral rating
MD
01/11ASTRAZENECA : SocGen Trims AstraZeneca PT, Maintains Buy Rating
MT
2020ASTRAZENECA : AlphaValue Upgrades AstraZeneca to Add from Reduce
MT
2020ASTRAZENECA : Receives a Sell rating from Goldman Sachs
MD
2020ASTRAZENECA : Liberum Trims AstraZeneca PT, Maintains Buy Rating
MT
2020ASTRAZENECA : Gets a Sell rating from DZ Bank
MD
2020Oppenheimer Downgraded Alexion Pharmaceuticals to Not Rated From Perform Foll..
MT
2020ALEXION PHARMACEUTICALS : RBC Capital Adjusts Alexion Pharmaceuticals PT to $175..
MT
2020Credit Suisse Downgrades Alexion to Neutral from Outperform on Sale to AstraZ..
MT
2020ASTRAZENECA : Receives a Buy rating from Kepler Cheuvreux
MD
2020ALEXION PHARMACEUTICALS : Wedbush Downgrades Alexion Pharmaceuticals to Neutral ..
MT
2020ASTRAZENECA : UBS gives a Neutral rating
MD
2020ASTRAZENECA : Credit Suisse reiterates its Buy rating
MD
2020ASTRAZENECA : Jefferies reiterates its Neutral rating
MD
2020ASTRAZENECA : Berenberg keeps its Buy rating
MD
2020ASTRAZENECA : Receives a Sell rating from Goldman Sachs
MD
2020Jefferies Affirms AstraZeneca at Hold, Lifts PT
MT
2020ASTRAZENECA : UBS remains Neutral
MD
2020Morgan Stanley Upgrades AstraZeneca to Overweight From Equal-Weight
MT
2020ASTRAZENECA : Upgraded to Buy by Morgan Stanley
MD
2020Sensex, Nifty end at record high on consumer goods boost
RE
2020Morgan Stanley Upgrades AstraZeneca to Overweight from Equalweight, Boosts Ta..
MT
2020WALL STREET WEEK AHEAD : After blazing energy rally, investors check the fuel ga..
RE
2020ASTRAZENECA : JP Morgan keeps its Buy rating
MD
2020Pfizer and BioNTech's Covid-19 Vaccine Wins U.K. Authorization -- 7th Update
DJ
2020UK approves Pfizer-BioNTech COVID-19 vaccine in world first
RE
2020UBS Upgrades AstraZeneca to Neutral From Sell
MT
2020ASTRAZENECA : UBS drops its Sell rating
MD
2020UBS Upgrades AstraZeneca to Neutral From Sell, Raises PT
MT
2020ASTRAZENECA : Vaccine is no shot in the arm yet for emerging markets
RE
2020AstraZeneca Gears Up to Vaccinate the World Against Covid-19
DJ
2020Morgan Stanley Maintains AstraZeneca at Equalweight, Lifts PT
MT
2020AstraZeneca, Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials..
DJ
2020ASTRAZENECA : Buy rating from Barclays
MD
2020ASTRAZENECA : Buy rating from JP Morgan
MD
2020ASTRAZENECA : Goldman Sachs remains a Sell rating
MD
2020ASTRAZENECA : vaccine fails to lift euro zone gvt bonds
RE
2020ASTRAZENECA : Buy rating from Berenberg
MD
2020ASTRAZENECA : UBS remains a Sell rating
MD
2020Rand jumps despite ratings downgrade, EM stocks rally on vaccine hopes
RE
2020European shares slip as jump in virus cases offsets vaccine hopes
RE
2020ASTRAZENECA : Gets a Neutral rating from Jefferies
MD
2020ASTRAZENECA : Berenberg reiterates its Buy rating
MD
2020Pfizer Says Covid Vaccine Is 95% Effective in Final Data, Will Seek Authoriza..
DJ
2020Pfizer's Covid-19 Vaccine 95% Effective in Final Results, Company to Seek App..
DJ
2020HSBC Upgrades AstraZeneca to Hold From Reduce
MT
2020HSBC Upgrades AstraZeneca to Hold from Reduce, Boosts PT
MT
2020ASTRAZENECA : Goldman Sachs reaffirms its Sell rating
MD
2020ASTRAZENECA : JP Morgan keeps its Buy rating
MD
2020ASTRAZENECA : Jefferies reaffirms its Neutral rating
MD
2020ASTRAZENECA : Goldman Sachs reaffirms its Sell rating
MD
2020ASTRAZENECA : Buy rating from Credit Suisse
MD
2020ASTRAZENECA : UBS gives a Sell rating
MD
2020ASTRAZENECA : JP Morgan reiterates its Buy rating
MD
2020AstraZeneca Expects Covid-19 Vaccine Trial Results This Year -- Update
DJ
2020AstraZeneca Expects Covid-19 Vaccine Trial Results This Year -- Earnings Revi..
DJ
2020ASTRAZENECA : COVID vaccine deliveries on ice as AstraZeneca awaits trial data
RE
2020ASTRAZENECA : Jefferies sticks Neutral
MD
2020ASTRAZENECA : Goldman Sachs keeps a Sell rating
MD
2020AstraZeneca Expects Covid-19 Vaccine Trial Results This Year
DJ
2020ASTRAZENECA : 3Q Net Profit Surged; Backs 2020 Guidance
DJ
2020ASTRAZENECA : COVID vaccine deliveries on ice as AstraZeneca awaits trial data
RE
2020ASTRAZENECA : JP Morgan reiterates its Buy rating
MD
2020ASTRAZENECA : UBS remains a Sell rating
MD
2020Travel, energy stocks drag UK shares lower, weighed by coronavirus fears
RE
2020ASTRAZENECA : Receives a Sell rating from Goldman Sachs
MD
2020ASTRAZENECA : Jefferies remains Neutral
MD
2020European shares tumble on J&J vaccine worries, banks slide
RE
2020ASTRAZENECA : Gets a Buy rating from JP Morgan
MD
2020ASTRAZENECA : Berenberg gives a Buy rating
MD
2020ASTRAZENECA : JP Morgan reaffirms its Buy rating
MD
2020ASTRAZENECA : JP Morgan reiterates its Buy rating
MD
1  2  3  4  5  6Next